51.   In May, the company warned about weak second-quarter earnings, and the shares tumbled, but in recent days, they have been climbing.

52.   In May, the company warned that demand for its scientific supplies is slowing because of cost cutting in the health care industry.

53.   In recent income reports, the company has warned of flagging perfume sales.

54.   In October, the company warned the delinquencies would hurt fourth-quarter profit.

55.   In May, the company warned that demand for its scientific supplies is slowing because of cost cutting in the health-care industry.

56.   In the meantime, the company warned that the second half would be difficult.

57.   In the broader market, U.S. stocks fell as companies warned that fourth-quarter profits will disappoint.

58.   In the filing, the company warned investors that in the past it has relied heavily on major customers for revenue.

59.   In the last six months, the company has warned of lower profit three times and analysts expect it to report a loss this year.

60.   Insurance companies warn that if they are forced to pick up the costs of the bill, those costs will ultimately be passed on to consumers.